A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the US Food and Drug Administration of making misleading claims that the ...
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...
Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party.
Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.
The Class I recall warned that the tip of guidewires or other medical devices may come into contact with the Impella pump during insertion, adjustment or removal. This interaction could result in ...
CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...